Immunome Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:IMNM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 24BuyUS$962,181Clay SiegallIndividual100,000US$9.78
21 Nov 24BuyUS$198,030Philip TsaiIndividual21,000US$9.43
21 Nov 24BuyUS$149,800Robert LechleiderIndividual15,805US$9.48
16 Aug 24BuyUS$97,608Jean-Jacques BienaimeIndividual7,000US$13.94
21 May 24BuyUS$1,388,072Clay SiegallIndividual100,000US$13.91
21 May 24BuyUS$27,140Jean-Jacques BienaimeIndividual2,000US$13.57

Insider Trading Volume

Insider Buying: IMNM insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IMNM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,708,3354.29%
Private Companies5,697,0939.02%
Hedge Funds8,768,96913.9%
Institutions45,964,90872.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.1%.


Top Shareholders

Top 25 shareholders own 86.95% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.5%
T. Rowe Price Group, Inc.
7,798,320US$86.4m32.2%0.01%
7.83%
Redmile Group, LLC
4,889,554US$54.2m0%3.19%
6.77%
FMR LLC
4,224,700US$46.8m0.33%no data
6.38%
BlackRock, Inc.
3,981,782US$44.1m5.93%no data
6.22%
EcoR1 Capital, LLC
3,879,415US$43.0m0%1.58%
5.59%
Janus Henderson Group plc
3,488,121US$38.6m10.3%0.02%
5.57%
Enavate Sciences
3,478,261US$38.5m0%no data
5.02%
The Vanguard Group, Inc.
3,131,568US$34.7m7.2%no data
3.72%
Arsenal Bridge Venture II, LLC
2,323,650US$25.7m-3.76%no data
3.5%
State Street Global Advisors, Inc.
2,187,466US$24.2m-7.48%no data
3.01%
Jefferies Financial Group Inc.,Asset Management Arm
1,875,892US$20.8m0%0.36%
2.5%
MorphImmune, Inc.
1,558,353US$17.3m0%no data
2.35%
Marshall Wace LLP
1,467,410US$16.3m-14.4%0.02%
1.98%
Opaleye Management Inc.
1,237,500US$13.7m12.2%2.44%
1.93%
Geode Capital Management, LLC
1,207,455US$13.4m13.6%no data
1.72%
Michael Rapoport
1,071,172US$11.9m0%no data
1.48%
Woodline Partners LP
924,392US$10.2m0.16%0.09%
1.4%
Avidity Partners Management, L.P.
873,891US$9.7m0%0.59%
1.38%
Brown Advisory Incorporated
860,381US$9.5m26.1%0.01%
1.17%
Victory Capital Management Inc.
730,785US$8.1m48.2%0.01%
1.15%
Tang Capital Management, LLC
720,000US$8.0m0%0.62%
1.08%
Sofinnova Investment, Inc.
676,766US$7.5m3.22%0.7%
1.06%
Longboat Family Office, LLC
660,479US$7.3m0%no data
0.83%
Clay Siegall
519,636US$5.8m23.8%no data
0.81%
Goldman Sachs Group, Investment Banking and Securities Investments
507,303US$5.6m209%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 00:03
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Immunome, Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lut Ming ChengCantor Fitzgerald & Co.
Michael SchmidtGuggenheim Securities, LLC
Lut Ming ChengJ.P. Morgan